1. |
Basso K, Dalla-Favera R. BCL6:master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis[J]. Adv Immunol, 2010, 105(10) :193-210.
|
2. |
Schlegel U, Jürgens A, Pels H. Primary central nervous system lymphomas (PCNSL):MRI response criteria revised[J]. Neurology, 2006, 66(8) :1287.
|
3. |
Thompsett AR, Ellison DW, Stevenson FK, et al. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity[J]. Blood, 1999, 94(5) :1738-1746.
|
4. |
Deckert M, Brunn A, Montesinos-Rongen M, et al. Primary lymphoma of the central nervous system:a diagnostic challenge[J]. Hematol Oncol, 2014, 32(2) :57-67.
|
5. |
Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma[J]. Nat Rev Neurol, 2013, 9(6) :317-327.
|
6. |
Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma[J]. Surv Ophthalmol, 2014, 59(5) :503-516.
|
7. |
Roth P, Martus P, Kiewe P, et al. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial[J]. Neurology, 2012, 79(9) :890-896.
|
8. |
Holdhoff M, Ambady P, Abdelaziz A, et al. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma[J]. Neurology, 2014, 83(3) :235-239.
|
9. |
Bierman PJ. Surgery for primary central nervous system lymphoma:is it time for reevaluation?[J]. Oncology (Williston Park), 2014, 28(7) :632-637.
|
10. |
Prica A, Chan K, Cheung M. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma:a cost-effectiveness analysis[J]. Neuro Oncol, 2014, 16(10) :1384-1391.
|